ICTI Implements Latest Version of MasterControl Training

March 22, 2006

Interactive Clinical Technologies Incorporated (ICTI) successfully implemented the latest version of MasterControl ™ Training, a program that links employee training directly with document change to make sure training activities are successfully completed and managed electronically. ICTI purchased this software from MasterControl Inc., and officially went live on February 21, 2006.

This new version of MasterControl™ connects employees to internal, controlled documentation, change control, and training control processes twenty four hours a day, seven days a week. It improves document quality by automating electronic approval processes, maintaining proper version control, and ensuring that audit trails are properly recorded. MasterControl™ connects the right individual to the right document to ensure that employees are working off the correct document version all the time.

ICTI’s Quality Assurance department finds that this training system helps manage and control role-based training requirements and employee capabilities while ensuring the required regulatory compliance. Whenever documents such as SOP’s are approved or revisions made, the change triggers training tasks to those employees affected by the change. This software’s flexibility allows ICTI to create and organize a variety of simple or complex training courses requiring users to understand their duties and demonstrate proficiency.

About ICTI and Almac Sciences

ICTI has been implementing adaptive randomization designs since 1999, and its technologies and services have been used in over 60 adaptive randomization studies. ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice and Web Response (iXRS) for patient randomization, dosing and clinical supply management; iDiary phone-based patient diaries; iTrial EDC for clinical trials data; and forecasting for clinical trials supplies planning.

Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and Almac Diagnostic Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact Jim Murphy or Meghan Adams US: 267-685-4284 / [email protected]


Back to news